During the last session, Hims & Hers Health Inc (NYSE:HIMS)’s traded shares were 15.77 million, with the beta value of the company hitting 2.05. At the end of the trading day, the stock’s price was $52.40, reflecting an intraday loss of -1.76% or -$0.94. The 52-week high for the HIMS share is $72.98, that puts it down -39.27 from that peak though still a striking 74.29% gain since the share price plummeted to a 52-week low of $13.47. The company’s market capitalization is $11.73B, and the average trade volume was 35.44 million shares over the past three months.
Hims & Hers Health Inc (HIMS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.44. HIMS has a Sell rating from 0 analyst(s) out of 13 analysts who have looked at this stock. 5 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 7 recommend a Buy rating for it.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Hims & Hers Health Inc (HIMS) registered a -1.76% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.76% in intraday trading to $52.40, hitting a weekly high. The stock’s 5-day price performance is -9.66%, and it has moved by 49.54% in 30 days. Based on these gigs, the overall price performance for the year is 210.43%.
The consensus price target of analysts on Wall Street is $68, which implies an increase of 22.94% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $68 and $68 respectively. As a result, HIMS is trading at a discount of -29.77% off the target high and -29.77% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 17.22%. While earnings are projected to return 24.57% in 2025, the next five years will return 35.15% per annum.
HIMS Dividends
Hims & Hers Health Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
The next largest institutional holding, with 14.57 million shares, is of BLACKROCK INC.’s that is approximately 6.7907% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $294.25 million.
Also, the Mutual Funds coming in first place with the largest holdings of Hims & Hers Health Inc (HIMS) shares are iShares Trust-iShares Core S&P Mid-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. Data provided on Apr 30, 2025 indicates that iShares Trust-iShares Core S&P Mid-Cap ETF owns about 6.19 shares. This amounts to just over 2.87 percent of the company’s overall shares, with a $324.38 million market value. The same data shows that the other fund manager holds slightly less at 5.47, or about 2.54% of the stock, which is worth about $286.4 million.
